We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$11B
AUM Growth
+$1.33B
Cap. Flow
+$1B
Cap. Flow %
9.09%
Top 10 Hldgs %
15.75%
Holding
2,862
New
750
Increased
597
Reduced
565
Closed
782

Top Sells

Rank Stock Value
1
F icon
Ford
F
+$53.1M
2
GM icon
General Motors
GM
+$51.9M
3
AVTR icon
Avantor
AVTR
+$42.9M
4
AAMI
Acadian Asset Management
AAMI
+$42.7M
5
COF icon
Capital One
COF
+$41M

Sector Composition

Rank Sector Weight
1 Financials 25.92%
2 Technology 13.18%
3 Industrials 8.76%
4 Consumer Discretionary 8.67%
5 Healthcare 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQQ icon
2126
Arqit Quantum
ARQQ
$349M
-1,604
Closed -$805K
ARRY icon
2127
Array Technologies
ARRY
$701M
-115,394
Closed -$2.14M
ASAN icon
2128
Asana
ASAN
$2.26B
-23,600
Closed -$2.45M
ATHM icon
2129
Autohome
ATHM
$2.51B
-25,318
Closed -$1.19M
ATI icon
2130
ATI
ATI
$28.5B
-37,700
Closed -$627K
ATKR icon
2131
Atkore
ATKR
$3.16B
-5,500
Closed -$478K
AUPH icon
2132
Aurinia Pharmaceuticals
AUPH
$2.2B
-51,900
Closed -$1.15M
AUR icon
2133
Aurora
AUR
$11.3B
-51,200
Closed -$508K
AVIR icon
2134
Atea Pharmaceuticals
AVIR
$442M
-104,378
Closed -$3.66M
AVY icon
2135
Avery Dennison
AVY
$13.9B
-1,741
Closed -$361K
AWI icon
2136
Armstrong World Industries
AWI
$7.53B
-2,600
Closed -$248K
AXS icon
2137
PUT
AXIS Capital
AXS
$7.27B
-721,400
Closed -$33.2M
AXSM icon
2138
CALL
Axsome Therapeutics
AXSM
$10.8B
-50,000
Closed -$1.65M
AXSM icon
2139
Axsome Therapeutics
AXSM
$10.8B
-1,317
Closed -$44K
AXSM icon
2140
PUT
Axsome Therapeutics
AXSM
$10.8B
-50,000
Closed -$1.65M
BAND
2141
Bandwidth Inc
BAND
$1.5B
-5,400
Closed -$487K
BBAR icon
2142
BBVA Argentina
BBAR
$3B
-10,600
Closed -$41K
BBVA icon
2143
Banco Bilbao Vizcaya Argentaria
BBVA
$161B
-341,232
Closed -$2.25M
BCAB icon
2144
BioAtla
BCAB
$5.35M
-187
Closed -$276K
BCE icon
2145
BCE
BCE
$22.3B
-4,400
Closed -$220K
BCH icon
2146
Banco de Chile
BCH
$21.7B
-16,200
Closed -$299K
BCS icon
2147
Barclays
BCS
$90.7B
-29,800
Closed -$307K
BCYC
2148
Bicycle Therapeutics
BCYC
$304M
-59,972
Closed -$2.49M
BDX icon
2149
Becton Dickinson
BDX
$52B
-7,341
Closed -$1.76M
BE icon
2150
Bloom Energy
BE
$60B
-16,813
Closed -$315K

Similar funds

Steve Schonfeld's Q4 2021 Portfolio in Review

As of Q4 2021, Steve Schonfeld held 2,862 positions worth $11B, up 14% from $9.68B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Steve Schonfeld deployed $1B of net new capital in Q4 2021, opening 750 new positions and adding to 597 existing holdings. Its largest new stake was Skyworks Solutions: 244,292 shares worth $37.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was General Motors, an estimated $51.9M trimmed.

  • Steve Schonfeld's largest Q4 2021 buy was Skyworks Solutions: 244,292 shares worth $37.9M.
  • Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $684M increase.
  • Steve Schonfeld's biggest Q4 2021 reduction was General Motors, cutting an estimated $51.9M.
  • Steve Schonfeld fully exited Ford in Q4 2021, selling an estimated $53.1M.
  • Steve Schonfeld's ten largest holdings make up 16% of its $11B portfolio in Q4 2021.
  • Steve Schonfeld opened 750 new positions and closed 782 in Q4 2021.
  • Steve Schonfeld's portfolio value rose 14% quarter-over-quarter to $11B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.